Details of the Drug
General Information of Drug (ID: DMLVMJH)
| Drug Name |
N,N'-dicyclohexyl-urea
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
1,3-Dicyclohexylurea; n,n'-dicyclohexylurea; 2387-23-7; Dicyclohexylurea; Urea, N,N'-dicyclohexyl-; UNII-ZV7823VVIM; ZV7823VVIM; CHEMBL1458; N,N'-Dicyclohexylurea, 98%; ADFXKUOMJKEIND-UHFFFAOYSA-N; MFCD00003829; Urea,3-dicyclohexyl-; Urea,N'-dicyclohexyl-; N,N inverted exclamation marka-Dicyclohexylurea; Urea, 1,3-dicyclohexyl-; dicylohexylurea; dicylcohexylurea; dicylohexyl urea; dicyclohexyl-urea; dicyclohexyl urea; DCW; EINECS 219-213-7; NSC 30023; NSC 17013; n.n'-dicyclohexylurea; Rupatadine Impurity 1; 1,3-dicyclohexyl-urea
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 224.34 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug Pharmacogenomic Perturbation (DPP)NEW | Click to Jump to the Detailed DPP Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


